Jack A. Khattar - 12 Feb 2024 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
President, CEO, Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
12 Feb 2024
Transactions value $
$0
Form type
4
Filing time
22 Feb 2024, 17:28:29 UTC
Previous filing
26 Dec 2023
Next filing
26 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Other +16,500 +1.9% 897,005 12 Feb 2024 Direct F1
transaction SUPN Common Stock Other -16,500 -1.6% 1,022,450 12 Feb 2024 By the KBT Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is filing this Form 4 to reflect the fact that 16,500 shares were transferred from the KBT Trust to the Reporting Person on February 12, 2024 without consideration and are now owned directly.